Glaukos Newsroom

Glaukos Cut to Underweight From Equal-Weight by Morgan Stanley

Dow JonesDec 2 21:34

Glaukos Price Target Announced at $120.00/Share by Morgan Stanley

Dow JonesDec 2 21:34

Glaukos Is Maintained at Buy by BTIG

Dow JonesNov 27 01:18

Glaukos Analyst Ratings

BenzingaNov 27 01:09

BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $149

Futu NewsNov 26 21:31

Stifel Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $145

Futu NewsNov 20 21:31

Truist Financial Maintains Glaukos(GKOS.US) With Buy Rating

Futu NewsNov 6 20:31

Mizuho Securities Maintains Glaukos(GKOS.US) With Hold Rating

Futu NewsNov 6 16:31

Uncertain Growth and Reimbursement Challenges Keep Glaukos's IDose at Hold Rating

TipRanksNov 6 16:01

Glaukos Is Maintained at Overweight by Wells Fargo

Dow JonesNov 5 23:21

Glaukos Analyst Ratings

BenzingaNov 5 23:12

Stifel Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $145

Futu NewsNov 5 21:31

A Quick Look at Today's Ratings for Glaukos(GKOS.US), With a Forecast Between $140 to $149

Futu NewsNov 5 21:07

Glaukos (GKOS) Receives a Buy From Piper Sandler

TipRanksNov 5 20:01

Analysts Offer Insights on Healthcare Companies: Glaukos (GKOS) and Vertex Pharmaceuticals (VRTX)

TipRanksNov 5 19:07

Glaukos' Strong Q3 2024 Performance and IDose's Growth Propel Buy Rating

TipRanksNov 5 18:26

Jefferies Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $155

Futu NewsOct 29 20:31

Truist Financial Maintains Glaukos(GKOS.US) With Buy Rating

Futu NewsOct 22 19:31

Analysts Conflicted on These Healthcare Names: Medpace Holdings (MEDP), McKesson (MCK) and Glaukos (GKOS)

TipRanksOct 22 19:07

Jefferies Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $145

Futu NewsOct 21 20:31